4
Changes in Ownership
Immunome Inc. Filed Acc 0001415889-24-023809
Chief Financial Officer sold 14,380 shares at $16.01 ($230,224)
- Chief Financial Officer acquired 42,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rosett Max Chief Financial Officer | 2024-09-19 | Option exercise | +42,000 | $1.05 | $44,100 | 61,856 | D |
| Rosett Max Chief Financial Officer | 2024-09-19 | Sale | −14,380 | $16.01 | $230,224 | 47,476 | D |
| Derivatives | |||||||
| Rosett Max Chief Financial Officer | 2024-09-19 | Option exercise · Stock option (right to buy) | −42,000 | 91,848 | D | ||
| Open-market sales · 14,380 sh · avg $16.01 · $230,224 | |||||||
Loading xslF345X05/form4-09202024_110913.xml…